In melanoma, RNF2 has been shown to be oncogenic and prometastatic, and RNF2 can promote metastasis through the inhibition of LTBP2, while its oncogenic function does not require it catalytic activity and RNF2 promotes cell proliferation through direct transcriptional upregulation of CCND2 [31]. This evidence concerns the gene LTBP2 and melanoma.